These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26435478)

  • 1. Apigenin blocks IKKα activation and suppresses prostate cancer progression.
    Shukla S; Kanwal R; Shankar E; Datt M; Chance MR; Fu P; MacLennan GT; Gupta S
    Oncotarget; 2015 Oct; 6(31):31216-32. PubMed ID: 26435478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice.
    Shukla S; Shankar E; Fu P; MacLennan GT; Gupta S
    PLoS One; 2015; 10(9):e0138710. PubMed ID: 26379052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
    Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
    Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: an in vitro and in vivo study.
    Shukla S; Gupta S
    Mol Carcinog; 2009 Mar; 48(3):243-252. PubMed ID: 18726972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of IKK inhibitor PS1145 on NF-kappaB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells.
    Yemelyanov A; Gasparian A; Lindholm P; Dang L; Pierce JW; Kisseljov F; Karseladze A; Budunova I
    Oncogene; 2006 Jan; 25(3):387-98. PubMed ID: 16170348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.
    Franzen CA; Amargo E; Todorović V; Desai BV; Huda S; Mirzoeva S; Chiu K; Grzybowski BA; Chew TL; Green KJ; Pelling JC
    Cancer Prev Res (Phila); 2009 Sep; 2(9):830-41. PubMed ID: 19737984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lycopene acts through inhibition of IκB kinase to suppress NF-κB signaling in human prostate and breast cancer cells.
    Assar EA; Vidalle MC; Chopra M; Hafizi S
    Tumour Biol; 2016 Jul; 37(7):9375-85. PubMed ID: 26779636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice.
    Sawada I; Hashimoto K; Sawada K; Kinose Y; Nakamura K; Toda A; Nakatsuka E; Yoshimura A; Mabuchi S; Fujikawa T; Itai A; Kimura T
    Int J Gynecol Cancer; 2016 May; 26(4):610-8. PubMed ID: 26905334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells.
    Kar S; Palit S; Ball WB; Das PK
    Apoptosis; 2012 Jul; 17(7):735-47. PubMed ID: 22453599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural flavonoid apigenin sensitizes human CD44
    Erdogan S; Turkekul K; Serttas R; Erdogan Z
    Biomed Pharmacother; 2017 Apr; 88():210-217. PubMed ID: 28107698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells.
    Gupta S; Afaq F; Mukhtar H
    Oncogene; 2002 May; 21(23):3727-38. PubMed ID: 12032841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IKK inhibitor suppresses epithelial-mesenchymal transition and induces cell death in prostate cancer.
    Ping H; Yang F; Wang M; Niu Y; Xing N
    Oncol Rep; 2016 Sep; 36(3):1658-64. PubMed ID: 27432067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism.
    Mirzoeva S; Franzen CA; Pelling JC
    Mol Carcinog; 2014 Aug; 53(8):598-609. PubMed ID: 23359392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms for apigenin-induced cell-cycle arrest and apoptosis of hormone refractory human prostate carcinoma DU145 cells.
    Shukla S; Gupta S
    Mol Carcinog; 2004 Feb; 39(2):114-26. PubMed ID: 14750216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB.
    Li X; Yang X; Liu Y; Gong N; Yao W; Chen P; Qin J; Jin H; Li J; Chu R; Shan L; Zhang R; Zhang W; Wang H
    Clin Cancer Res; 2013 Jun; 19(11):2917-28. PubMed ID: 23620411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apigenin potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells.
    Wu DG; Yu P; Li JW; Jiang P; Sun J; Wang HZ; Zhang LD; Wen MB; Bie P
    Toxicol Lett; 2014 Jan; 224(1):157-64. PubMed ID: 24148603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics.
    Lang L; Shay C; Zhao X; Teng Y
    J Exp Clin Cancer Res; 2017 Aug; 36(1):112. PubMed ID: 28830537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apigenin attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model.
    Shukla S; MacLennan GT; Fu P; Gupta S
    Pharm Res; 2012 Jun; 29(6):1506-17. PubMed ID: 22139534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking IKKα expression inhibits prostate cancer invasiveness.
    Mahato R; Qin B; Cheng K
    Pharm Res; 2011 Jun; 28(6):1357-69. PubMed ID: 21191633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of NF-κB-related proteins and their modulation during TNF-α-provoked apoptosis in prostate cancer cells.
    Rodríguez-Berriguete G; Fraile B; Paniagua R; Aller P; Royuela M
    Prostate; 2012 Jan; 72(1):40-50. PubMed ID: 21520161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.